|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Depreciation, amortization, and other | |||||
| Stock-based compensation expense, net | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Disbursement prefunding | |||||
| Customer funds receivable | |||||
| Prepaid expenses and other assets | |||||
| Operating lease right-of-use assets | |||||
| Accounts payable | |||||
| Customer liabilities | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Capitalized internal-use software costs | |||||
| Net collections (originations) from consumer receivables | |||||
| Cash paid for acquisition, net of acquired cash, cash equivalents, and restricted cash | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock in connection with ESPP | |||||
| Cash paid for repurchase of common stock | |||||
| Proceeds from revolving credit facility borrowings | |||||
| Repayments of revolving credit facility borrowings | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Proceeds from issuance of common stock upon initial public offering and private placements, net of offering costs, underwriting discounts and commissions | |||||
| Repayment of non-recourse promissory note | |||||
| Proceeds from issuance of Series E and F convertible preferred stock, net of issuance costs | |||||
| Net change in customer funds assets and liabilities | |||||
| Cash paid for settlement of amounts previously held back for acquisition consideration | |||||
| Payment of debt issuance costs | |||||
| Repayment of assumed indebtedness | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Vesting of early exercised options | |||||
| Noncash issuance of common stock in connection with ESPP | |||||
| Stock-based compensation expense capitalized to internal-use software | |||||
| IPO and debt issuance costs incurred but not yet paid | |||||
| Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | |||||
| Reconciliation of cash, cash equivalents, and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in prepaid expenses and other current assets | |||||
| Restricted cash included in other noncurrent assets, net | |||||
Loading...